D2HGDH Antibodies

Santa Cruz Biotechnology delivers a wide array of D2HGDH monoclonal antibodies for investigating D2-hydroxyglutarate dehydrogenase (D2HGDH) in various biological processes. Multiple experimental applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). D2HGDH is a key enzyme involved in the metabolism of D-2-hydroxyglutarate, a metabolite implicated in several pathological conditions, including cancer and neurodegenerative diseases. By regulating D-2-hydroxyglutarate levels, D2HGDH plays a crucial role in cellular energy production and redox balance. Understanding D2HGDH function is essential for identifying potential therapeutic targets and biomarkers in various diseases. Researchers can utilize specific monoclonal antibodies to examine D2HGDH expression patterns across different tissues and cellular compartments. Advanced imaging techniques combined with D2HGDH monoclonal antibodies enable detailed visualization of protein localization and interactions. Secondary antibodies conjugated to horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) provide flexible detection options. Santa Cruz Biotechnology monoclonal antibodies for D2HGDH research contribute to advancing scientific understanding of metabolic disorders and potential therapeutic interventions.